Abstract
Pulmonary infection has been an important concern in patients with non-small cell lung cancer. It is well-known that chemotherapy may increase the infection rate by suppressing the immune system. Whether the clinical outcome of pulmonary infection is association with immunotherapy is still unclear. Mass cytometry is a next-generation flow cytometry platform with multiparametric analyses. Previous studies of mass cytometry showed that exhausted T cell were implicated in disease progression and response to immunotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
